Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Debt Ratio (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Debt Ratio data on record, last reported at 0.04 in Q3 2025.

  • For Q3 2025, Debt Ratio rose 12.38% year-over-year to 0.04; the TTM value through Sep 2025 reached 0.04, up 12.38%, while the annual FY2024 figure was 0.04, 18.53% up from the prior year.
  • Debt Ratio reached 0.04 in Q3 2025 per GANX's latest filing, down from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.05 in Q2 2025 and bottomed at 0.02 in Q1 2021.
  • Average Debt Ratio over 5 years is 0.03, with a median of 0.03 recorded in 2023.
  • Peak YoY movement for Debt Ratio: tumbled 76.83% in 2021, then soared 86.83% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.02 in 2021, then surged by 40.59% to 0.03 in 2022, then rose by 21.87% to 0.03 in 2023, then rose by 18.53% to 0.04 in 2024, then rose by 6.93% to 0.04 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.04 in Q3 2025, 0.05 in Q2 2025, and 0.04 in Q1 2025.